BDBM437051 6-[3,4-Difluoro-5-(trifluoromethyl)phenyl]-3-methyl-1-(pyridazin-3- ylmethyl)imidazo[4,5-b]pyridin-2-one::US10617676, Example 387::US11207298, Example 387

SMILES Cn1c2ncc(cc2n(Cc2cccnn2)c1=O)-c1cc(F)c(F)c(c1)C(F)(F)F

InChI Key InChIKey=TXRVVAFJUFYXIG-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 437051   

TargetGlutamate receptor ionotropic, NMDA 1/2B(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM437051(US10617676, Example 387 | 6-[3,4-Difluoro-5-(trifl...)
Affinity DataIC50: 22nMAssay Description:NMDA receptors are ion channels that are highly permeable to Ca2+ ions, rendering it possible to monitor NMDA receptor function using cell-based calc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
US Patent

TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM437051(US10617676, Example 387 | 6-[3,4-Difluoro-5-(trifl...)
Affinity DataIC50: 22nMAssay Description:NMDA receptors are ion channels that are highly permeable to Ca2+ ions, rendering it possible to monitor NMDA receptor function using cell-based calc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/13/2020
Entry Details
US Patent